View in EDS HTML Full Text PDF Full Text

Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.

Saved in:
Bibliographic Details
Title: Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.
Authors: Vogl TJ (AUTHOR), Naguib NN (AUTHOR), Nour-Eldin NE (AUTHOR), Eichler K (AUTHOR), Zangos S (AUTHOR), Gruber-Rouh T (AUTHOR), Vogl, Thomas J1 (AUTHOR), Naguib, Nagy N N (AUTHOR), Nour-Eldin, Nour-Eldin A (AUTHOR), Eichler, Katrin (AUTHOR), Zangos, Stefan (AUTHOR), Gruber-Rouh, Tatjana (AUTHOR)
Source: European Radiology. Jan2010, Vol. 20 Issue 1, p173-180. 8p.
Abstract: The purpose of this study was to evaluate the efficacy of transarterial chemoembolization (TACE) using different drug combinations in the treatment of breast cancer liver metastases in terms of local tumor control and survival rate. A total of 208 patients (mean age 56.4 years, range 29-81) with unresectable hepatic metastases of breast cancer were repeatedly treated with TACE at 4-week intervals. In total, 1,068 chemoembolizations were performed (mean 5.1 sessions/patient, range 3-25). The chemotherapy protocol consisted of mitomycin-C only (8 mg/m(2); n = 76), mitomycin-C with gemcitabine (n = 111), and gemcitabine only (1,000 mg/m(2); n = 21). Embolization was performed with lipiodol and starch microspheres. Tumor response was evaluated by MRI according to RECIST criteria. Survival rates were calculated using Kaplan-Meier method. For all protocols, local tumor control was partial response 13% (27/208), stable disease 50.5% (105/208), and progressive disease 36.5% (76/208). The 1-, 2-, and 3-year survival rates after TACE were 69, 40, and 33%. Median and mean survival times from the start of TACE were 18.5 and 30.7 months. Treatment with mitomycin-C only showed median and mean survival times of 13.3 and 24 months, with gemcitabine only they were 11 and 22.3 months, and with a combination of mitomycin-C and gemcitabine 24.8 and 35.5 months. TACE is an optional therapy for treatment of liver metastases in breast cancer patients with better results from the combined chemotherapy protocol. [ABSTRACT FROM AUTHOR]
Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Engineering Source
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: egs
DbLabel: Engineering Source
An: 105285614
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Vogl+TJ%22">Vogl TJ</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naguib+NN%22">Naguib NN</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nour-Eldin+NE%22">Nour-Eldin NE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eichler+K%22">Eichler K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zangos+S%22">Zangos S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gruber-Rouh+T%22">Gruber-Rouh T</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vogl%2C+Thomas+J%22">Vogl, Thomas J</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naguib%2C+Nagy+N+N%22">Naguib, Nagy N N</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nour-Eldin%2C+Nour-Eldin+A%22">Nour-Eldin, Nour-Eldin A</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eichler%2C+Katrin%22">Eichler, Katrin</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zangos%2C+Stefan%22">Zangos, Stefan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gruber-Rouh%2C+Tatjana%22">Gruber-Rouh, Tatjana</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Radiology%22">European Radiology</searchLink>. Jan2010, Vol. 20 Issue 1, p173-180. 8p.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The purpose of this study was to evaluate the efficacy of transarterial chemoembolization (TACE) using different drug combinations in the treatment of breast cancer liver metastases in terms of local tumor control and survival rate. A total of 208 patients (mean age 56.4 years, range 29-81) with unresectable hepatic metastases of breast cancer were repeatedly treated with TACE at 4-week intervals. In total, 1,068 chemoembolizations were performed (mean 5.1 sessions/patient, range 3-25). The chemotherapy protocol consisted of mitomycin-C only (8 mg/m(2); n = 76), mitomycin-C with gemcitabine (n = 111), and gemcitabine only (1,000 mg/m(2); n = 21). Embolization was performed with lipiodol and starch microspheres. Tumor response was evaluated by MRI according to RECIST criteria. Survival rates were calculated using Kaplan-Meier method. For all protocols, local tumor control was partial response 13% (27/208), stable disease 50.5% (105/208), and progressive disease 36.5% (76/208). The 1-, 2-, and 3-year survival rates after TACE were 69, 40, and 33%. Median and mean survival times from the start of TACE were 18.5 and 30.7 months. Treatment with mitomycin-C only showed median and mean survival times of 13.3 and 24 months, with gemcitabine only they were 11 and 22.3 months, and with a combination of mitomycin-C and gemcitabine 24.8 and 35.5 months. TACE is an optional therapy for treatment of liver metastases in breast cancer patients with better results from the combined chemotherapy protocol. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=105285614
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00330-009-1525-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 173
    Titles:
      – TitleFull: Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vogl TJ
      – PersonEntity:
          Name:
            NameFull: Naguib NN
      – PersonEntity:
          Name:
            NameFull: Nour-Eldin NE
      – PersonEntity:
          Name:
            NameFull: Eichler K
      – PersonEntity:
          Name:
            NameFull: Zangos S
      – PersonEntity:
          Name:
            NameFull: Gruber-Rouh T
      – PersonEntity:
          Name:
            NameFull: Vogl, Thomas J
      – PersonEntity:
          Name:
            NameFull: Naguib, Nagy N N
      – PersonEntity:
          Name:
            NameFull: Nour-Eldin, Nour-Eldin A
      – PersonEntity:
          Name:
            NameFull: Eichler, Katrin
      – PersonEntity:
          Name:
            NameFull: Zangos, Stefan
      – PersonEntity:
          Name:
            NameFull: Gruber-Rouh, Tatjana
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2010
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-print
              Value: 09387994
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: European Radiology
              Type: main
ResultId 1